Cargando…

Contemporary Pharmacotherapeutics and the Management of Aggressive Behavior in an Adolescent Animal Model of Maladaptive Aggression

OBJECTIVE: Antipsychotic and anticonvulsant medications are increasingly being used as pharmacotherapeutic treatments for maladaptive aggression in youth, yet no information is available regarding whether these drugs exhibit aggression- specific suppression in preclinical studies employing adolescen...

Descripción completa

Detalles Bibliográficos
Autores principales: Einberger, Clare, Puckett, Amanda, Ricci, Lesley, Jr., Richard Melloni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236798/
https://www.ncbi.nlm.nih.gov/pubmed/32329300
http://dx.doi.org/10.9758/cpn.2020.18.2.188
_version_ 1783536214495723520
author Einberger, Clare
Puckett, Amanda
Ricci, Lesley
Jr., Richard Melloni
author_facet Einberger, Clare
Puckett, Amanda
Ricci, Lesley
Jr., Richard Melloni
author_sort Einberger, Clare
collection PubMed
description OBJECTIVE: Antipsychotic and anticonvulsant medications are increasingly being used as pharmacotherapeutic treatments for maladaptive aggression in youth, yet no information is available regarding whether these drugs exhibit aggression- specific suppression in preclinical studies employing adolescent animal models of maladaptive aggression. This study examined whether the commonly used antipsychotics medications haloperidol and risperidone and the anticonvulsant medication valproate exert selective aggression-suppressing effects using a validated adolescent animal model of maladaptive aggression. METHODS: Twenty-seven-day old Syrian hamsters (Mesocricetus auratus) were administered testosterone for 30 consecutive days during the first 4 weeks of adolescent development. The following day (during late adolescence), experimental animals received a single dose of haloperidol (0.00, 0.025, 0.50, 1.0 mg/kg), risperidone (0.00, 0.01, 0.03, 1.0 mg/kg), or valproate (0.00, 1.0, 5.0, 10.0 mg/kg) and tested for offensive aggression using the Resident/Intruder Paradigm. As a baseline, non-aggressive behavioral control, a separate set of pubertal hamsters was treated with sesame oil vehicle during the first 4 weeks of adolescence and then tested for aggression during late adolescence in parallel with the haloperidol, risperidone or valproate-treated experimental animals. RESULTS: Risperidone and valproate selectively reduced the highly impulsive and intense maladaptive aggressive phenotype in a dose-dependent fashion. While haloperidol marginally reduced aggressive responding, its effects were non-specific as the decrease in aggression was concurrent with reductions in a several ancillary (non-aggressive) behaviors. CONCLUSION: These studies provide pre-clinical evidence that the contemporary pharmacotherapeutics risperidone and valproate exert specific aggression-suppressing effects in an adolescent animal model of maladaptive aggression.
format Online
Article
Text
id pubmed-7236798
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Korean College of Neuropsychopharmacology
record_format MEDLINE/PubMed
spelling pubmed-72367982020-05-31 Contemporary Pharmacotherapeutics and the Management of Aggressive Behavior in an Adolescent Animal Model of Maladaptive Aggression Einberger, Clare Puckett, Amanda Ricci, Lesley Jr., Richard Melloni Clin Psychopharmacol Neurosci Original Article OBJECTIVE: Antipsychotic and anticonvulsant medications are increasingly being used as pharmacotherapeutic treatments for maladaptive aggression in youth, yet no information is available regarding whether these drugs exhibit aggression- specific suppression in preclinical studies employing adolescent animal models of maladaptive aggression. This study examined whether the commonly used antipsychotics medications haloperidol and risperidone and the anticonvulsant medication valproate exert selective aggression-suppressing effects using a validated adolescent animal model of maladaptive aggression. METHODS: Twenty-seven-day old Syrian hamsters (Mesocricetus auratus) were administered testosterone for 30 consecutive days during the first 4 weeks of adolescent development. The following day (during late adolescence), experimental animals received a single dose of haloperidol (0.00, 0.025, 0.50, 1.0 mg/kg), risperidone (0.00, 0.01, 0.03, 1.0 mg/kg), or valproate (0.00, 1.0, 5.0, 10.0 mg/kg) and tested for offensive aggression using the Resident/Intruder Paradigm. As a baseline, non-aggressive behavioral control, a separate set of pubertal hamsters was treated with sesame oil vehicle during the first 4 weeks of adolescence and then tested for aggression during late adolescence in parallel with the haloperidol, risperidone or valproate-treated experimental animals. RESULTS: Risperidone and valproate selectively reduced the highly impulsive and intense maladaptive aggressive phenotype in a dose-dependent fashion. While haloperidol marginally reduced aggressive responding, its effects were non-specific as the decrease in aggression was concurrent with reductions in a several ancillary (non-aggressive) behaviors. CONCLUSION: These studies provide pre-clinical evidence that the contemporary pharmacotherapeutics risperidone and valproate exert specific aggression-suppressing effects in an adolescent animal model of maladaptive aggression. Korean College of Neuropsychopharmacology 2020-05-31 2020-05-31 /pmc/articles/PMC7236798/ /pubmed/32329300 http://dx.doi.org/10.9758/cpn.2020.18.2.188 Text en Copyright © 2020, Korean College of Neuropsychopharmacology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Einberger, Clare
Puckett, Amanda
Ricci, Lesley
Jr., Richard Melloni
Contemporary Pharmacotherapeutics and the Management of Aggressive Behavior in an Adolescent Animal Model of Maladaptive Aggression
title Contemporary Pharmacotherapeutics and the Management of Aggressive Behavior in an Adolescent Animal Model of Maladaptive Aggression
title_full Contemporary Pharmacotherapeutics and the Management of Aggressive Behavior in an Adolescent Animal Model of Maladaptive Aggression
title_fullStr Contemporary Pharmacotherapeutics and the Management of Aggressive Behavior in an Adolescent Animal Model of Maladaptive Aggression
title_full_unstemmed Contemporary Pharmacotherapeutics and the Management of Aggressive Behavior in an Adolescent Animal Model of Maladaptive Aggression
title_short Contemporary Pharmacotherapeutics and the Management of Aggressive Behavior in an Adolescent Animal Model of Maladaptive Aggression
title_sort contemporary pharmacotherapeutics and the management of aggressive behavior in an adolescent animal model of maladaptive aggression
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236798/
https://www.ncbi.nlm.nih.gov/pubmed/32329300
http://dx.doi.org/10.9758/cpn.2020.18.2.188
work_keys_str_mv AT einbergerclare contemporarypharmacotherapeuticsandthemanagementofaggressivebehaviorinanadolescentanimalmodelofmaladaptiveaggression
AT puckettamanda contemporarypharmacotherapeuticsandthemanagementofaggressivebehaviorinanadolescentanimalmodelofmaladaptiveaggression
AT riccilesley contemporarypharmacotherapeuticsandthemanagementofaggressivebehaviorinanadolescentanimalmodelofmaladaptiveaggression
AT jrrichardmelloni contemporarypharmacotherapeuticsandthemanagementofaggressivebehaviorinanadolescentanimalmodelofmaladaptiveaggression